Synaptogenix Inc (SNPX)

[runncoach]

Biogen AD debacle over. They aren't even going to enroll the 6000 patients into a confirmatory trial. https://www.fiercepharma.com/pharma/biogen-terminates-aduhelm-study-no-thanks-restricted-medicare-coverage

Not sure how it impacts the space. Some seem to want to think if Aduhelm could get approval without a major large trial based on "iffy" data that only slowed progression, then similar results from trials could gain approval as well....but as this has played out I think unless a drug blows the socks off for efficacy, the FDA won't go down this road again and end up with egg on their face. IMO, if you don't have a drug that actually reverses AD, you have a long and expensive trial road ahead.